Phase transformations during processing and in vitro degradation of porous calcium polyphosphates

  • Youxin Hu
  • Robert Pilliar
  • Marc Grynpas
  • Rita Kandel
  • Ulrike Werner-Zwanziger
  • Mark Filiaggi
Biomaterials Synthesis and Characterization Original Research
Part of the following topical collections:
  1. Biomaterials Synthesis and Characterization


A 2-Step sinter/anneal treatment has been reported previously for forming porous CPP as biodegradable bone substitutes [9]. During the 2-Step annealing treatment, the heat treatment used strongly affected the rate of CPP degradation in vitro. In the present study, x-ray diffraction and 31P solid state nuclear magnetic resonance were used to determine the phases that formed using different heat treating processes. The effect of in vitro degradation (in PBS at 37 °C, pH 7.1 or 4.5) was also studied. During CPP preparation, β-CPP and γ-CPP were identified in powders formed from a calcium monobasic monohydrate precursor after an initial calcining treatment (10 h at 500 °C). Melting of this CPP powder (at 1100 °C), quenching and grinding formed amorphous CPP powders. Annealing powders at 585 °C (Step-1) resulted in rapid sintering to form amorphous porous CPP. Continued annealing to 650 °C resulted in crystallization to form a multi-phase structure of β-CPP primarily plus lesser amounts of α-CPP, calcium ultra-phosphates and retained amorphous CPP. Annealing above 720 °C and up to 950 °C transformed this to β-CPP phase. In vitro degradation of the 585 °C (Step-1 only) and 650 °C Step-2 annealed multi-phase samples occurred significantly faster than the β-CPP samples formed by Step-2 annealing at or above 720 °C. This faster degradation was attributable to preferential degradation of thermodynamically less stable phases that formed in samples annealed at 650 °C (i.e. α-phase, ultra-phosphate and amorphous CPP). Degradation in lower pH solutions significantly increased degradation rates of the 585 and 650 °C annealed samples but had no significant effect on the β-CPP samples.


Solid State Nuclear Magnetic Resonance Phosphate Buffer Saline Solution Sinter Neck Bone Void Filler Calcium Polyphosphate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Funding for this study was provided by grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada.


  1. 1.
    Pilliar RM, Filiaggi MJ, Wells JD, et al. Porous calcium polyphosphate scaffolds for bone substitute applications—in vitro characterization. Biomaterials. 2001;22:963–72.CrossRefGoogle Scholar
  2. 2.
    Grynpas MD, Pilliar RM, Kandel RA, et al. Porous calcium polyphosphate scaffolds for bone substitute applications—in vivo characterization. Biomaterials. 2002;23:2063–70.CrossRefGoogle Scholar
  3. 3.
    Comeau PA, Frei H, Yang C, Fernlund G, Rossi F. In vivo evaluation of calcium polyphosphate for bone regeneration. J Biomater Appl. 2012. doi: 10.1177/0885328211401933.Google Scholar
  4. 4.
    Shanjani Y, Hu Y, Toyserkani E, Grynpas M, Kandel RA, Pilliar RM. Solid freeform fabrication of porous calcium polyphosphate structures for bone substitute applications: in vivo studies. J Biomed Mater Res B. 2013;101:972–80.CrossRefGoogle Scholar
  5. 5.
    Hu Y, Shanjani Y, Toyserkani E, Grynpas M, Wang R, Pilliar R. Porous calcium polyphosphate bone substitutes: additive manufacturing versus conventional gravity sinter processing—Effect on structure and mechanical properties. J Biomed Mater Res B. 2014;102:274–83.CrossRefGoogle Scholar
  6. 6.
    Pilliar R, Kandel R, Grynpas M, Hu Y. Porous calcium polyphosphate as load-bearing bone substitutes: in vivo study. J Biomed Mater Res B. 2013;101:1–8.CrossRefGoogle Scholar
  7. 7.
    Kandel RA, Grynpas M, Pilliar R, Lee J, Waldman S, Zalzal P, Hurtig M. Repair of osteochondral defects with biphasic cartilage-calcium polyphosphate constructs in a sheep model. Biomaterials. 2006;27:4120–31.CrossRefGoogle Scholar
  8. 8.
    Pilliar RM, Kandel RA, Grynpas MD, Theodoropoulos J, Hu Y, Allo B, Changoor A Calcium polyphosphate particulates for bone void filler applications. J Biomed Mater Res B 2016. doi: 10.1002/jbm.b.33623.
  9. 9.
    Pilliar RM, Hong J, Santerre PJ, Method of manufacture of porous inorganic structures, U.S. Patent No. 7494614, 2009.Google Scholar
  10. 10.
    Filiaggi M, Pilliar RM, Hong J. On the sintering characteristics of calcium polyphosphate. Key Eng Mater. 2001;192–195:171–4.CrossRefGoogle Scholar
  11. 11.
    Ding YL, Chen YW, Qin YJ, Shi GQ, Yu XX, Wan CX. Effect of polymerization degree of calcium polyphosphate on its microstructure and in vitro degradation performance. J Mater Sci Mater Med. 2008;19:1291–5.CrossRefGoogle Scholar
  12. 12.
    Qui K, Zhao XJ, Wan CX, Zhao CS, Chen YW. Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials. 2006;27:1277–86.CrossRefGoogle Scholar
  13. 13.
    Guo L, Li H. Phase transformations and structure characterization of calcium polyphosphate during sintering. J Mater Sci. 2004;39:7041–7.CrossRefGoogle Scholar
  14. 14.
    Fleisch H, Schubler D, Maerki J, Frissard I. Inhibition of aortic calcification by means of pyrophosphate and polyphosphates. Nature. 1965;207:1300–1.CrossRefGoogle Scholar
  15. 15.
    Francis MD. The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates. Calcif Tissue Res. 1969;3:151–62.CrossRefGoogle Scholar
  16. 16.
    Omelon SJ, Grynpas MD. Relationship between polyphosphate chemistry, biochemistry and apatite biomineralization. Chem Rev. 2008;108:4694–715.CrossRefGoogle Scholar
  17. 17.
    McIntosh AO, Jablonski WL. X-ray diffraction powder patterns of calcium phosphates Anal. Chem. 1956;28:1424–7.Google Scholar
  18. 18.
    Hill WL, Faust GT, Reynolds DS. The Binary system P2O5-2CaO·P2O5. Am J Sci. 1944;242:457–77.CrossRefGoogle Scholar
  19. 19.
    Weil M, Puchberger M. Schmedt auf der Günne J, Weber J, Synthesis, crystal structure, and characterization (vibrational and solid-state 31P MAS NMR spectroscopy) of the high-temperature modification of calcium catena-polyphosphate(V). Chem Mater. 2007;19:5067–73.CrossRefGoogle Scholar
  20. 20.
    Pourpoint F, Kolassiba A, Gervais C, Azais T, Bonhomme-Coury L, Bonhomme C, Mauri F. First principles calculations of NMR parameters in biocompatible materials science: the case study of calcium phosphates, β-and γ-Ca(PO3)2 combination with MAS-J experiments. Chem Mater. 2007;19:6367–9.CrossRefGoogle Scholar
  21. 21.
    Witter R, Hartmann P, Vogel J, Jäger C. Measurements of chain length distributions in calcium phosphate glasses using 2D 31P double quantum NMRSolid State. NMR. 1998;13:189–200.Google Scholar
  22. 22.
    Jäger C, Hartmann P, Witter R, Braun M. New 2D NMR experiments for determining the structure of phosphate glasses: a review. J Non Cryst Solids. 2000;263&264:61–72.CrossRefGoogle Scholar
  23. 23.
    Feike M, Graf R, Schnell I, Jäger C, Spiess HW. Structure of crystalline phosphates from 31P double-quantum NMR spectroscopy. J Am Chem Soc. 1996;118:9631–4.CrossRefGoogle Scholar
  24. 24.
    Griffith E. General phospate chemistry (as applied to fibers). Phosphate fibers. New York: Plenum Press; 1995. p. 57–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Youxin Hu
    • 1
  • Robert Pilliar
    • 1
    • 2
  • Marc Grynpas
    • 1
    • 3
  • Rita Kandel
    • 1
    • 3
  • Ulrike Werner-Zwanziger
    • 4
  • Mark Filiaggi
    • 5
  1. 1.Institute of Biomaterials and Biomedical EngineeringUniversity of TorontoTorontoCanada
  2. 2.Faculty of DentistryUniversity of TorontoTorontoCanada
  3. 3.Mount Sinai HospitalTorontoCanada
  4. 4.Department of ChemistryDalhousie UniversityHalifaxCanada
  5. 5.Faculty of DentistryDalhousie UniversityHalifaxCanada

Personalised recommendations